Approaches to the prevention and management of radiation colitis



Radiation colitis refers to the characteristic changes in the mucosa of the colon and rectum secondary to pelvic radiation. Based on the interval from radiation to mucosal changes or symptoms, there are two well-defined forms of radiation colitis: acute, manifested by mucosal sloughing causing diarrhea, mucus discharge, and tenesmus; and chronic, characterized by obstructed defecation or ischemia of the mucosa due to obliterative endarteritis and resulting in mucosal telangiectasias, mucosal pallor, and friability causing rectal bleeding. Up to 25% of all patients receiving pelvic radiation develop mild symptoms, and 2% to 3% develop moderate to severe symptoms. Radiation colitis can be difficult to treat in some patients. There are several options for treating its symptoms. Argon plasma coagulation is the most common method of treating telangiectasias. Topical formaldehyde has also been used for distal telangiectasias. Obstructed defecation caused by radiation strictures (which are very fibrotic) usually can be treated successfully with stool softeners, colonic dilation, or steroid injection. Surgery should be avoided if possible because of its technical difficulty and the high incidence of postoperative complications such as anastomotic leak and fistula formation. New advances in radiation delivery techniques (eg, intensity-modulated radiation therapy) using specialized computer algorithms and medications such as amifostine may decrease the incidence of radiation colitis.

References and Recommended Reading

  1. 1.
    Babb RR: Radiation proctitis: A review. Am J Gastroenterol 1996, 91:1309–1311.PubMedGoogle Scholar
  2. 2.
    Cho LC, Antoine JE: Radiation injury to the gastrointestinal tract. In Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, edn 8. Edited by Feldman M, Friedman LS, and Brandt LJ. Philadelphia: Saunders Elsevier; 2006;813–826.Google Scholar
  3. 3.
    Gilinsky NH, Burns DG, Barbezat GO, et al.: The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. Q J Med 1983, 52:40–53.PubMedGoogle Scholar
  4. 4.
    Schultheiss TE, Lee WR, Hunt MA, et al.: Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37:3–11.PubMedGoogle Scholar
  5. 5.
    Schultheiss TE, Lee WR, Hunt MA, Lee R: Incidence of and factors related to late complications in coformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1995, 32:643–649.PubMedCrossRefGoogle Scholar
  6. 6.
    Beard CJ, Propert KJ, Rieker PP, et al.: Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997, 15:223–229.PubMedGoogle Scholar
  7. 7.
    Teshima T, Hanks GE, Hanlon AL, et al.: Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 1997, 39:77–83.PubMedGoogle Scholar
  8. 8.
    Snyder KM, Stock RG, Hong SM, et al.: Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001, 50:335–341.PubMedCrossRefGoogle Scholar
  9. 9.
    Anseline PF, Lavery IC, Fazio VW, et al.: Radiation injury of the rectum: evaluation of surgical treatment. Ann Surg 1981, 194:716–724PubMedCrossRefGoogle Scholar
  10. 10.
    Lucarotti ME, Mountford RA, Bartolo DC: Surgical management of radiation injury. Dis Colon Rectum 1991, 34:865–869.PubMedCrossRefGoogle Scholar
  11. 11.
    O’Brien PC, Hamilton CS, Denham, JW, Gourlay R: Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58:75–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Bernhard EJ, McKenna WG, Muschel RJ: Radiosensitivity and the cell cycle. Cancer J Sci Am 1999, 5:194–204.PubMedGoogle Scholar
  13. 13.
    Jones BA, Gores GJ: Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol 1997, 273:G1174–G1188.PubMedGoogle Scholar
  14. 14.
    Metcalfe A, Streuli C: Epithelial apoptosis. Bioassays 1997, 19:711–720.CrossRefGoogle Scholar
  15. 15.
    Potten CS, Booth C: The role of radiation induced and spontaneous apoptosis in the homeostasis of gastrointestinal epithelium. Comp Biochem Physiol 1997, 3:473–478.Google Scholar
  16. 16.
    Wang J, Zheng H, Sung CC, et al.: Cellular sources of transforming growth factor bisoforms in early and chronic radiation enteropathy. Am J Pathol 1998, 5:1531–1540.Google Scholar
  17. 17.
    Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ: Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994, 32:29–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Richter KK, Langberg CW, Sung CC, Hauer-Jensen M: Increased transforming growth factor β (TGF-β) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int J Radiat Oncol Biol Phys 1997, 39:187–195.PubMedGoogle Scholar
  19. 19.
    Skwarchuk MW, Travis EL: Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains. Int J Radiat Oncol Biol Phys 1998, 42:169–178.PubMedGoogle Scholar
  20. 20.
    Isaka Y, Brees DK, Ikegaya K, et al.: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996, 2:418–423.PubMedCrossRefGoogle Scholar
  21. 21.
    Herskind C, Bamberg M, Rodemann HP: The role of cytokines in the development of normal tissue reactions after radiotherapy. Strahlenther Onkol 1998, 174(Suppl 3):12–15.PubMedGoogle Scholar
  22. 22.
    Cohen L, Creditor M: Iso-effect tables for tolerance of irradiated normal human tissue. Int J Radiat Oncol Biol Phys 1983, 2:233–241.Google Scholar
  23. 23.
    Melian E, Mageras GS, Fuks Z, et al.: Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 1997, 38:73–81.PubMedGoogle Scholar
  24. 24.
    Ling CC, Burman C, Chui CS, et al.: Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996, 35:721–730.PubMedGoogle Scholar
  25. 25.
    Fraass BA, Kessler ML, McShan DL, et al.: Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy. Semin Radiat Oncol 1999, 9:60–77.PubMedCrossRefGoogle Scholar
  26. 26.
    Hanks GE, Hanlon AL, Schultheiss TE, et al.: Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998, 41:501–510.PubMedCrossRefGoogle Scholar
  27. 27.
    Rossi CJ Jr, Slater JD, Reyes-Molyneux N, et al.: Particle beam radiation therapy in prostate cancer: Is there an advantage? Semin Radiat Oncol 1998, 8:115–123.PubMedCrossRefGoogle Scholar
  28. 28.
    Zietman AL, DeSilvio ML, Slater JD, et al.: Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005, 294:1233–1239.PubMedCrossRefGoogle Scholar
  29. 29.
    Keefe DM, Schubert MM, Elting LS, et al.: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007, 109:820–831.PubMedCrossRefGoogle Scholar
  30. 30.
    Schuchter LM, Glick J: The current status of WR-2721 (amifostine): a chemotherapy and radiation therapy protector. Biologic Ther Cancer 1993, 2:1–10.Google Scholar
  31. 31.
    Liu T, Liu Y, He S, et al.: Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer 1992, 69:2820–2825.PubMedCrossRefGoogle Scholar
  32. 32.
    Athanassiou H, Antonadou D, Coliarakis N, et al.: Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys 2003, 56:1154–1160.PubMedCrossRefGoogle Scholar
  33. 33.
    Kouloulias VE, Kouvaris JR, Pissakas G, et al.: Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys 2005, 62:486–493.PubMedGoogle Scholar
  34. 34.
    Taylor JG, DiSario JA, Buchi KN: Argon laser therapy for hemorrhagic radiation proctitis. Long-term results. Gastrointest Endosc 1993, 39:641–644.PubMedCrossRefGoogle Scholar
  35. 35.
    Silva RA, Correia AJ, Dias LM, et al.: Argon plasma coagulation therapy for hemorrhagic radiation proctosigmoiditis. Gastrointest Endosc 1999, 50:221–224.PubMedCrossRefGoogle Scholar
  36. 36.
    Fantin AC, Binek J, Suter WR, Meyenberger C: Argon beam coagulation for treatment of symptomatic radiation-induced proctitis. Gastrointest Endosc 1999, 49:515–518.PubMedCrossRefGoogle Scholar
  37. 37.
    Taieb, S, Rolachon, A, Cenni, JC, et al.: Effective use of argon plasma coagulation in the treatment of severe radiation proctitis. Dis Colon Rectum 2001, 44:1766–1771.PubMedCrossRefGoogle Scholar
  38. 38.
    Tjandra JJ, Sengupta S: Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis. Dis Colon Rectum 2001, 44:1759–1765.PubMedCrossRefGoogle Scholar
  39. 39.
    Ben Soussan E, Mathieu N, Roque I, Antonietti M: Bowel explosion with colonic perforation during argon plasma coagulation for hemorrhagic radiation-induced proctitis. Gastrointest Endosc 2003, 57:412–413.PubMedCrossRefGoogle Scholar
  40. 40.
    Jensen DM, Machicado GA, Cheng S, et al.: A randomized prospective study of endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal bleeding from radiation telangiectasia. Gastrointest Endosc 1997, 45:20–25.PubMedCrossRefGoogle Scholar
  41. 41.
    Mathai V, Seow-Choen F: Endoluminal formalin therapy for haemorrhagic radiation proctitis. Br J Surg 1995, 82:190.PubMedCrossRefGoogle Scholar
  42. 42.
    de Parades V, Etienney I, Bauer P, et al.: Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis—an effective but not risk-free procedure: a prospective study of 33 patients. Dis Colon Rectum 2005, 48:1535–1541.PubMedCrossRefGoogle Scholar
  43. 43.
    Haas EM, Bailey HR, Farragher I: Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis. Dis Colon Rectum 2007, 50:213–217.PubMedCrossRefGoogle Scholar
  44. 44.
    Cullen SN, Frenz M, Mee A: Treatment of haemorrhagic radiation-induced proctopathy using small volume topical formalin instillation. Aliment Pharmacol Ther 2006, 23:1575–1579.PubMedCrossRefGoogle Scholar
  45. 45.
    Kochhar R, Patel F, Dhar A, et al.: Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci 1991, 36:103–107.PubMedCrossRefGoogle Scholar
  46. 46.
    Kochhar R, Sriram PV, Sharma SC: Natural history of the radiation proctosigmoiditis treated with topical sucralfate. Dig Dis Sci 1999, 44:973–978.PubMedCrossRefGoogle Scholar
  47. 47.
    Leach RM, Rees PJ, Wilmhurst P: Hyperbaric oxygen therapy. BMJ 1998, 317:1140–1143.PubMedGoogle Scholar
  48. 48.
    Baum CA, Biddle WL, Miner PB Jr: Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis. Dig Dis Sci 1989, 34:758–760.PubMedCrossRefGoogle Scholar
  49. 49.
    Talley NA, Chen F, King D, et al.: Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trial. Dis Colon Rectum 1997, 40:1046–1050.PubMedCrossRefGoogle Scholar
  50. 50.
    Cavcic J, Turcic J, Martinac P, et al.: Metronidazole in the treatment of chronic radiation proctitis: clinical trial. Croat Med J 2000, 41:314–318.PubMedGoogle Scholar
  51. 51.
    Wurzer H, Schafhalter-Zoppoth I, Brandstatter G: Hormonal therapy in chronic radiation colitis. Am J Gastroenterol 1998, 93:2536–2538.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologyCleveland Clinic FoundationClevelandUSA

Personalised recommendations